34. Gulley JL, Arlen PM, Madan, et al. Immunologic and prognostic factors associated with overall survival employing a poxviral- based PSA vaccine in metastatic castrate- resistant prostate cancer. Cancer Immunol Immunother. 2010.59(5):663- 674. 35.